Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

Mutations in alpha-synuclein and Leucine-rich repeat kinase 2 (LRRK2) are linked to autosomal dominant forms of Parkinson's disease (PD). However, little is known about any potential pathophysiological interplay between these two PD-related genes. Here we show in transgenic mice that although overexpression of LRRK2 alone did not cause neurodegeneration, the presence of excess LRRK2 greatly accelerated the progression of neuropathological abnormalities developed in PD-related A53T alpha-synuclein transgenic mice. Moreover, we found that LRRK2 promoted the abnormal aggregation and somatic accumulation of alpha-synuclein in A53T mice, which likely resulted from the impairment of microtubule dynamics, Golgi organization, and the ubiquitin-proteasome pathway. Conversely, genetic ablation of LRRK2 preserved the Golgi structure and suppressed the aggregation and somatic accumulation of alpha-synuclein, and thereby delayed the progression of neuropathology in A53T mice. These findings demonstrate that overexpression of LRRK2 enhances alpha-synuclein-mediated cytotoxicity and suggest inhibition of LRRK2 expression as a potential therapeutic option for ameliorating alpha-synuclein-induced neurodegeneration.

Pubmed ID: 20064389


  • Lin X
  • Parisiadou L
  • Gu XL
  • Wang L
  • Shim H
  • Sun L
  • Xie C
  • Long CX
  • Yang WJ
  • Ding J
  • Chen ZZ
  • Gallant PE
  • Tao-Cheng JH
  • Rudow G
  • Troncoso JC
  • Liu Z
  • Li Z
  • Cai H



Publication Data

December 24, 2009

Associated Grants

  • Agency: NINDS NIH HHS, Id: P50 NS038377
  • Agency: Intramural NIH HHS, Id: Z01 AG000944-01
  • Agency: Intramural NIH HHS, Id: Z01 AG000959-04
  • Agency: Intramural NIH HHS, Id: Z01 AG000959-05
  • Agency: Intramural NIH HHS, Id: ZIA AG000944-02
  • Agency: Intramural NIH HHS, Id: ZIA AG000945-02
  • Agency: Intramural NIH HHS, Id: ZIA AG000959-06

Mesh Terms

  • Animals
  • Brain
  • Disease Progression
  • Gene Expression Regulation
  • Genetic Predisposition to Disease
  • Golgi Apparatus
  • Inclusion Bodies
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Microtubules
  • Mutation
  • Nerve Degeneration
  • Neurons
  • Parkinson Disease
  • Protein-Serine-Threonine Kinases
  • alpha-Synuclein